In one of the more expansive financial resolutions in recent corporate history, the Sterling Biotech matter has culminated in a substantial ₹9,800 crore recovery. Delivered by industrialist Nitin J. Sandesara and his group, the resolution reflects a structured and comprehensive settlement, resulting in a balanced outcome for both the lending institutions and the promoters.